Alessandra Viel

11PUBLICATIONS
194CO-AUTHORS
Molecular targetsCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 25, 2023
<i>MLH1</i> Promoter Methylation Could Be the Second Hit in Lynch Syndrome Carcinogenesis.

Ileana Wanda Carnevali, Giulia Cini, Laura Libera

|Nov 11, 2022
Biallelic <i>PMS2</i> Mutations in a Family with Uncommon Clinical and Molecular Features.

Monica Pedroni, Maurizio Ponz de Leon, Luca Reggiani Bonetti

|Oct 06, 2022
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.

Christopher Hakkaart, John F Pearson, Louise Marquart

|Jul 27, 2022
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer.

Michele Bartoletti, Giorgio Giorda, Alessandra Viel

|Oct 27, 2021
Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants.

Anastasia Dell'Elice, Giulia Cini, Mara Fornasarig

|Jul 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

Daniel R Barnes, Valentina Silvestri, Goska Leslie

Pageof 2